Engineered mutant α-ENaC subunit mRNA delivered by lipid nanoparticles reduces amiloride currents in cystic fibrosis–based cell and mice models

Anindit Mukherjee, Kelvin D. MacDonald, Jeonghwan Kim, Michael Henderson, Yulia Eygeris, Gaurav Sahay

Science Advances · 2020 · 25 citations · 46 references

DOIFull text

Open access

Concepts

Abstract

KO mice. These data suggest that mRNA-based ENaC inhibition is a powerful strategy for reducing mucus dehydration and has therapeutic potential for treating CF in all patients, independent of genotype.

References

46